<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd" xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>00000caa a22000003i 4500</leader>
  <controlfield tag="001">UP-1685594773862388480</controlfield>
  <controlfield tag="003">Buklod</controlfield>
  <controlfield tag="005">20210316102406.0</controlfield>
  <controlfield tag="006">m     |  |        </controlfield>
  <controlfield tag="007">ta</controlfield>
  <controlfield tag="008">210316s2018    xx      r    |||| u|eng d</controlfield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(iLib)UPBAG-00039513670</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
   <subfield code="a">STII-DOST</subfield>
   <subfield code="d">BAG</subfield>
   <subfield code="e">rda</subfield>
  </datafield>
  <datafield tag="041" ind1="0" ind2=" ">
   <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2="0">
   <subfield code="a">ARTICLE-2675</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Singh, Anuradha</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">In silico studies on N- (Pyridin-2-yl) Thiobenzamides as NNRTIs against wild and mutant HIV-1 strains</subfield>
   <subfield code="c">by Anuradha Singh, Vishal Kumar Singh, Rajesh Verma, and Ramendra K. Singh.</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
   <subfield code="c">2018.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
   <subfield code="a">pages 37-46</subfield>
   <subfield code="b">color illustrations</subfield>
   <subfield code="c">26 cm</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
   <subfield code="a">text</subfield>
   <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
   <subfield code="a">unmediated</subfield>
   <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
   <subfield code="a">volume</subfield>
   <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
   <subfield code="a">Includes bibliographical references (pages 34-35)</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
   <subfield code="a">In the present study, keeping the Lipinskiâ??s Rule of Five in focus, a series of new 4-(4-benzenesulfonylamino)-N-(5-substituted-pyridin-2-yl)-thiobenzamides bearing different substituents at the C-4 position of benzenesulfonylamino ring have been designed as NNRTIs of wild-type (WT) and mutant HIV-1 strains. Molecules having drug-like character were further docked into the active domain of wild-type (WT) RT/1 with entry code (PDB: ID 3mec) and K103N/TYR181 mutant RT/2 complex (PDB: ID 3BGR) using Discovery Studio 2.5 software. Analysis of the docking results revealed that all molecules formed hydrogen bonds with active amino acids (Lys101, Lys103, Tyr181, and Tyr318) and exhibited Ï?-stacking interactions with Tyr181, Tyr188, Phe227, and Trp229 present in the NNIBP with both WT and mutant HIV-1 RT. The designed ligands adopted â??horseshoe/seahorseâ?? conformation inside the NNIBP like other second generation NNRTIs and formed more stable complexes (total interaction energy found in the range of (-) 54 - (-) 77 kcal/mol) with HIV-1 RT in comparison to etravirine and rilpivirine (-)61.43 and (-)50.23 Kcal/mol, respectively. Consequently, lower EC50 values were predicted for N- (Pyridin-2-yl) derivatives. Structure-activity relationships (SARs) are discussed in terms of a possible interaction with the RT binding site, depending on the nature of the substituent at ring A and ring C.</subfield>
  </datafield>
  <datafield tag="650" ind1="0" ind2="4">
   <subfield code="a">Chemistry.</subfield>
  </datafield>
  <datafield tag="650" ind1="0" ind2="4">
   <subfield code="a">Lipinski?s rule of five.</subfield>
  </datafield>
  <datafield tag="650" ind1="0" ind2="4">
   <subfield code="a">Hiv-1 reverse transcription.</subfield>
  </datafield>
  <datafield tag="650" ind1="0" ind2="4">
   <subfield code="a">Structure-activity relationships (sars).</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Singh, Vishal Kumar</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Verma,Rajesh</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Singh, Ramendra K.</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="a">The Philippine Journal of Science</subfield>
   <subfield code="g">Vol. 147, no. 1, March 2018.</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="a">Request full-text access via UPB University Library through</subfield>
   <subfield code="u">https://forms.gle/KZjBv7aRtY6jiL5E9</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="z">(viewed 16 March 2021)</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
   <subfield code="a">FI</subfield>
  </datafield>
  <datafield tag="852" ind1="0" ind2=" ">
   <subfield code="a">UPBAG</subfield>
   <subfield code="b">UPBAG-MAIN</subfield>
   <subfield code="h">ARTICLE-2675</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
   <subfield code="a">Analytics</subfield>
  </datafield>
 </record>
</collection>
